| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Quant Healthcare Fund Reg (G) |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.04 |
| Equity |
99.41 |
| Treasury Bill |
6.23 |
| Trep |
-5.60 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
47.26% |
| Top 10 Holdings |
83.11% |
| Top 25 Holdings |
115.14% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
52.93 |
| Derivatives |
16.69 |
| Miscellaneous |
10.21 |
| Healthcare |
8.34 |
| Food Beverage & Tobacco |
7.05 |
| SOV |
6.23 |
| Retail |
3.63 |
| Industrial Products |
0.56 |
| Cash |
-5.64 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
0.00 |
| PE Ratio |
45.70 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| TREPS 02-Mar-2026 DEPO 10 |
10.63 |
| SMS Pharmaceuticals Limited |
9.98 |
| Anthem Biosciences Limited |
9.26 |
| Sequent Scientific Limited |
9.05 |
| Aster DM Healthcare Limited |
8.34 |
| Zydus Wellness Limited |
7.05 |
| Pfizer Limited |
6.93 |
| Alivus Life Sciences |
6.41 |
| ICICI PRUDENTIAL LIFE INSURA L |
5.56 |
| Aurobindo Pharma Limited |
5.36 |
| Biocon Ltd |
4.89 |
| HDFC Life Insurance Co Ltd |
4.65 |
| Aurobindo Pharma Limited |
4.54 |
| HDFC Life Insurance Co Ltd |
4.49 |
| MedPlus Health Services Limited |
3.63 |
| Concord Biotech Limited |
2.91 |
| Glaxosmithkline Pharma Ltd |
2.39 |
| ICICI Prudential Life Insurance Co Ltd |
1.95 |
| 91 Days Treasury Bill 22-May-2026 |
1.69 |
| Gland Pharma Limited |
1.46 |
| 91 Days Treasury Bill 14-May-2026 |
0.85 |
| 91 Days Treasury Bill 07-May-2026 |
0.85 |
| 91 Days Treasury Bill 30-Apr-2026 |
0.85 |
| 91 Days Treasury Bill 23-Apr-2026 |
0.85 |
| 91 Days Treasury Bill 27-Mar-2026 |
0.57 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
